MetaVia Presents Higher-Dose Phase 1 Results for DA-1726 at EASL Congress 2026, Supporting Potential in Obesity and MASH

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. MRVL

Go back to MetaVia Presents Higher-Dose Phase 1 Results for DA-1726 at EASL Congress 2026, Supporting Potential in Obesity and MASH
(NASDAQ: MTVA) Delayed: 1.74 -0.27 (13.43%)
Previous Close $2.01    52 Week High $ 
Open $1.88    52 Week Low $ 
Day High $2.17    P/E N/A 
Day Low $1.72    EPS $ 
Volume 583,502